Publication Name	World Journal of Gastroenterology
Manuscript ID	7078
Country	Iran

Received	2013-11-03 20:13
Peer-Review Started	2013-11-04 20:29
To Make the First Decision	2014-01-15 17:39
Return for Revision	2014-01-21 09:44
Revised	2014-02-11 15:57
Second Decision	2014-04-09 09:21
Accepted by Journal Editor-in-Chief
Accepted by Executive Editor-in-Chief	2014-04-09 11:01
Articles in Press	2014-05-23 10:59
Publication Fee Transferred
Edit the Manuscript by Language Editor	2014-05-01 19:37
Typeset the Manuscript	2014-08-08 15:03
Publish the Manuscript Online	2014-08-20 18:38

ISSN	1007-9327 (print) and 2219-2840 (online)
Open Access
Copyright
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Gastroenterology & Hepatology
Manuscript Type	Autobiography
Article Title	Beneficial effect of butyrate, Lactobacillus casei and L-carnitine combination in preference to each in experimental colitis
Manuscript Source	Invited Manuscript
All Author List	Mahsa Moeinian, Seyedeh Farnaz Ghasemi-Niri, Shilan Mozaffari, Amir Hossein Abdolghaffari, Maryam Baeeri, Mona Navaea-Nigjeh and Mohammad Abdollahi
Funding Agency and Grant Number	Funding Agency Grant Number Tehran University of Medical Sciences (partially)
Corresponding Author	Mohammad Abdollahi, Professor, Department of Toxicology and Pharmacology, Toxicology and Poisoning Research Center, Faculty of Pharmacy and Pharmaceutical Sciences Research Center, Tehran University of Medical Sciences, Tehran 1417614411, Iran. mohammad@tums.ac.ir
Key Words	Butyrate; L-carnitine; Colitis; Inflammatory bowel disease; Oxidative stress; Lactobacillus casei; Probiotic
Core Tip	Inflammatory bowel disease (IBD) is among the common diseases in the world that have no absolute cure yet. Although corticosteroids, immunosuppressants, and aminosalicylates are conventionally used in management of IBD, their side effects reduce patients’ compliance. In this paper, we have shown that the combination of butyrate, Lactobacillus casei, and, L-carnitine reduces the amount of oxidative stress within the colon and provides significant anti-inflammatory effects. Optimistically, the proposed combination is from components with no serious side effects and is more economical to manufacture.
Publish Date	2014-08-20 18:38
Citation	Moeinian M, Ghasemi-Niri SF, Mozaffari S, Abdolghaffari AH, Baeeri M, Navaea-Nigjeh M, Abdollahi M. Beneficial effect of butyrate, Lactobacillus casei and L-carnitine combination in preference to each in experimental colitis. World J Gastroenterol 2014; 20(31): 10876-10885
URL	http://www.wjgnet.com/1007-9327/full/v20/i31/10876.htm
DOI	http://dx.doi.org/10.3748/wjg.v20.i31.10876

Full Article (PDF)	WJG-20-10876.pdf
Full Article (Word)	WJG-20-10876.doc
Manuscript File	7078-Review.docx
Answering Reviewers	7078-Answering reviewers.pdf
Copyright License Agreement	7078-Copyright Assignment.pdf
Non-Native Speakers of English Editing Certificate	7078-Language certificate.pdf
Peer-review Report	7078-Peer review(s).pdf
Scientific Editor Work List	7078-Scientific editor work list.doc